tyloxapol has been researched along with clofibric acid in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (33.33) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Bagaria, A; Bruseghini, L; Vilageliu, J | 1 |
| Borensztajn, J; Davidson, NO; Fu, T; Mukhopadhyay, D | 1 |
| Cheng, L; Guo, M; He, Y; Jiang, H; Liu, J; Ren, C; Shi, Y; Sun, M; Wang, B; Wang, W; Wang, X; Xie, Y; Xu, X | 1 |
3 other study(ies) available for tyloxapol and clofibric acid
| Article | Year |
|---|---|
Hypolipemic activity of plafibride.
Topics: Animals; Cholesterol; Clofibrate; Clofibric Acid; Dogs; Fatty Acids, Nonesterified; Hypolipidemic Agents; Lipoproteins; Male; Mice; Mice, Inbred Strains; Polyethylene Glycols; Rats; Rats, Inbred Strains; Triglycerides | 1981 |
The peroxisome proliferator-activated receptor alpha (PPARalpha) agonist ciprofibrate inhibits apolipoprotein B mRNA editing in low density lipoprotein receptor-deficient mice: effects on plasma lipoproteins and the development of atherosclerotic lesions.
Topics: Animals; Aorta; Apolipoproteins B; Arteriosclerosis; Blotting, Western; Cholesterol; Clofibric Acid; Cytoplasm; Female; Fibric Acids; Intestinal Mucosa; Lipid Metabolism; Lipoproteins; Lipoproteins, LDL; Liver; Mice; Mice, Inbred C57BL; Mice, Transgenic; Peroxisome Proliferators; Polyethylene Glycols; Receptors, Cytoplasmic and Nuclear; Receptors, LDL; RNA; RNA Editing; RNA, Messenger; Time Factors; Transcription Factors; Triglycerides | 2004 |
The combination of sesamol and clofibric acid moieties leads to a novel potent hypolipidemic agent with antioxidant, anti-inflammatory and hepatoprotective activity.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Antioxidants; Benzodioxoles; Clofibric Acid; Dose-Response Relationship, Drug; Hyperlipidemias; Hypolipidemic Agents; Inflammation; Liver; Mice; Mice, Inbred Strains; Molecular Docking Simulation; Molecular Structure; Oxidative Stress; Phenols; Polyethylene Glycols; Protective Agents; Structure-Activity Relationship | 2021 |